Role of Bacterial Porins in Antibiotic Susceptibility of Gram-Negative Bacteria

Bacterial and Eukaryotic Porins: Structure, Function, Mechanism

Volumn , Issue , 2005, Pages 41-59

  Pagés, Jean Marie ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Antibiotic resistance; Antibiotic susceptibility of gram negative bacteria; Bacterial porins; in vitro mutagenesis analyses of porins

Indexed keywords

EID: 21244486973     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/3527603875ch.3     Document Type: Chapter

References (75)

1. M. S. Weiss, A. Kreusch, E. Schiltz, U. Nestel, W. Welte, J. Weckesser, G. E. Schulz, The structure of porin from Rhodobacter capsulatus at 1.8 Å resolution. FEBS Lett 1991, 280, 379-382.
2. S. W. Cowan, T. Schirmer, G. Rummel, M. Steiert, R. Ghosh, R. A. Pauptit, J. N. Jansonius, J. P. Rosenbusch, Crystal structures explain functional properties of two E. coli porins. Nature 1992, 358, 727-733.
3. W. Achouak, T. Heulin, J.-M. Pagès, Multiple facets of bacterial porins. FEMS Microbiol Lett 2001, 9887, 1-7.
4. J. Lin, S. Huang, Q. Zhang, Outer membrane proteins: key players for bacterial adaptation in host niches. Microbes Infect 2002, 4, 325-331.
5. H. Nikaido, Outer membrane, In: Neidhardt, F. C. (Ed.) Escherichia coli and Salmonella Cellular and Molecular Biology. ASM Press, Washington, DC, 1996, pp. 29-47.
6. H. Nikaido, S. Normark, Sensitivity of Escherichia coli to various β-lactams is determined by the interplay of outer membrane permeability and degradation by periplasmic β-lactamases: a quantitative predictive treatment. Mol Microbiol 1987, 1, 29-36.
7. F. Yoshimura, H. Nikaido, Diffusion of β-lactam antibiotics through the porin channels of Escherichia coli K-12. Antimicrob Agents Chemother 1985, 27, 84-92.
8. Nikaido H., Prevention of drug access to bacterial targets: permeability barriers and active efflux. Science 1994, 264, 382-388.
9. H. Nikaido, E. Y. Rosenberg, J. Foulds, Porin channels in Escherichia coli: studies with β-lactams in intact cells. J Bacteriol 1983, 353, 232-240.
10. K. Poole, Outer membranes and efflux: the path to multidrug resistance in Gram-negative bacteria. Curr Pharm Biotechnol 2002, 3, 77-98.
11. D. M. Livermore, Of Pseudomonas, porins, pumps and carbapenems. J Antimicrob Chemother 2001, 47, 247-250.
12. R. E. Hancock, F. S. Brinkman, Function of Pseudomonas porins in uptake and efflux. Annu Rev Microbiol 2002, 56, 17-38.
13. J. Trias, J. Dufresne, R. C. Levesque, H. Nikaido, Decreased outer membrane permeability in imipenem resistant mutants of P aeruginosa. Antimicrob Agents Chemother 1989, 33, 1201-1206.
14. J.-P. Pirnay, D. De Vos, D. Mossialos, A. Vanderkelen, P. Cornelis, M. Zizi, Analysis of the Pseudomonas aeruginosa oprD gene from clinical and environmental isolates. Environ Microbiol 2002, 4, 872-882.
15. K. Okamoto, N. Gotoh, T. Nishino, Pseudomonas aeruginosa reveals high intrinsic resistance to penem antibiotics: penem resistance mechanisms and their interplay. Antimicrob Agents Chemother 2001, 45, 1964-1971.
16. H. Pai, J. W. Kim, J. Kim, J. H. Lee, K. W. Choe, N. Gotoh, Carbapenem resistance in Pseudomonas aeruginosa clinical isolates. Antimicrob Agents Chemother 2001, 45, 480-484.
17. M. M. Ochs, M. Bains, R. E. Hancock, Role of putative loops 2 and 3 in imipenem passage through the specific porin OprD of Pseudomonas aeruginosa. Antimicrob Agents Chemother 2000, 44, 1983-1985.
18. S. F. Epp, T. Kolher, P. Plesiat, M. Michea-Hamzehpour, J. Frey, J. C. Pechere, C-terminal region of Pseudomonas aeruginosa outer membrane porin OprD modulates susceptibility to meropenem. Antimicrob Agents Chemother 2001, 45, 1780-1787.
19. J. Trias, H. Nikaido, Protein D2 channel of the P aeruginosa outer membrane has a binding site for basic amino acids and peptides. J Biol Chem 1990, 265, 15680-15684.
20. H. Huang, D. Jeanteur, F. Pattus, R. E. Hancock, Membrane topology and sitespecific mutagenesis of Pseudomonas aeruginosa porin OprD. Mol Microbiol 1995, 16, 931-941.
21. J. L. Mainardi, P. Mugnier, A. Coutrot, A. Buu-Hoi, E. Collatz, L. Gutmann, Carbapenem resistance in a clinical isolate of Citrobacter freundii. Antimicrob Agents Chemother 1997, 41, 2352-2354.
22. A. A. Medeiros, T. F. O'Brien, E. Y. Rosenberg, H. Nikaido, Loss of OmpC porin in a strain of Salmonella typhimurium causes increased resistance to cephalosporins during therapy. J Infect Dis 1987, 156, 751-757.
23. A. S. Low, F. M. MacKenzie, I. M. Gould, I. R. Booth, Protected environments allow parallel evolution of a bacterial pathogen in a patient subjected to long-term antibiotic therapy. Mol Microbiol 2001, 42, 619-630
24. E. H. Lee, M. H. Nicolas, M. D. Kitzis, G. Pialoux, E. Collatz, L. Gutmann, Association of two resistance mechanisms in a clinical isolate of Enterobacter cloaccae with high-level resistance to imipenem. Antimicrob Agents Chemother 1991, 35, 1093-1098.
25. C. Bornet, A. Davin-Regli, C. Bosi, J.-M. Pagés, C. Bollet, Imipenem resistance of Enterobacter aerogenes mediated by outer membrane impermeability. J Clin. Microbiol 2000, 38, 1048-1052.
26. C. Ardanuy, J. Linares, M. A. Dominguez, S. Hernandez-Alles, V. J. Benedi, L. Martinez-Martinez. Outer membrane profiles of clonally related Klebsiella pneumoniae isolates from clinical samples and activities of cephalosporins and carbapenems. Antimicrob Agents Chemother 1998, 42, 1636-1640.
27. L. Martinez-Martinez, A. Pascual, S. Hernandez-Alles, D. Alvarez-Diaz, A. I. Suarez, J. Tran, V. J. Benedi, G. A. Jacoby, Roles of β-lactamases and porins in activities of carbapenems and cephalosporins against Klebsiella pneumoniae. Antimicrob Agents Chemother 1999, 43, 1669-1673.
28. A. Raimondi, A. Traverso, H. Nikaido, Imipenem- and meropenem-resistant mutants of Enterobacter cloaccae and Proteus rettgeri lack porins. Antimicrob Agents Chemother 1991, 35, 1174-1180.
29. L. Armand-Lefevre, V Leflon-Guibout, J. Bredin, A. Amor, J.-M. Pagès, M.-H. Nicolas-Chanoine, Imipenem resistance in Salmonella enterica serovar when related to porin loss and CMY-4 β-lactamase production. Antimicrob Agents Chemother 2003, 47, 1165-1168.
30. A. S. Ghosh, A. K. Kar, M. Kundu, Impaired imipenem uptake associated with alterations in outer membrane proteins and lipopolysaccharides in imipenem-resistant Shigella dysenteriae. J Antimicrob Chemother 1999, 43, 195-201.
31. K. Marumo, T. Nagaki, Y. Nakamura, Evaluation of high-level carbapenem resistance in atypical Serratia marcescens by a comparison with its revertants. J Antimicrob Chemother 1996, 38, 47-58.
32. R. N. Charrel, J.-M. Pagès, P. De Micco, M. Malléa, Prevalence of outer membrane porin alteration in β-lactam-antibiotic-resistant Enterobacter aerogenes. Antimicrob Agents Chemother. 1996, 40, 2854-2858.
33. K. Hirai, H. Aoyama, S. Suzue, T. Irikura, S. Iyobe, S. Mitsuhashi, Isolation and characterization of norfloxacin-resistant mutants of Escherichia coli K-12. Antimicrob Agents Chemother 1986, 30, 248-253.
34. J. Chevalier, M. Malléa, J.-M. Pagès, Comparative aspects of the diffusion of norfloxacin, cefepime and spermine through the F porin channel of Enterobacter cloacae. Biochem J 2000, 348, 223-227.
35. M. Berlanga, N. Ruiz, J. Hernandez-Borrel, T. Montero, M. Vinas, Role of the outer membrane in the accumulation of quinolones by Serratia marcescens. Can J Microbiol 2000, 46, 716-722.
36. M. Michea-Hamzehpour, Y. X. Furet, J. C. Pechere, Role of protein D2 and lipopolysaccharide in diffusion of quinolones through the outer membrane of Pseudomonas aeruginosa. Antimicrob Agents Chemother 1991, 35, 2091-2097.
37. M. Malléa, J. Chevalier, C. Bornet, A. Eyraud, A. Davin-Régli, C. Bollet, J.-M. Pagès, Porin alteration and active efflux: two in vivo drug resistance strategies used by Enterobacter aerogenes. Microbiology 1998, 144, 3003-3009.
38. C. Bosi, A. Davin-Régli, C. Bornet, M. Malléa, J.-M. Pagès, C. Bollet, Most Enterobacter aerogenes strains in France belong to a prevalent clone. J Clin Microbiol 1999, 37, 2165-2169.
39. H. Yigit, G. J. Anderson, J. W. Biddle, C. D. Steward, J. K. Rasheed, L. L. Valera, J. E. McGowan Jr, F. C. Tenover, Carbapenem resistance in a clinical isolate of Enterobacter aerogenes is associated with decreased expression of OmpF and OmpC porin analogs. Antimicrob Agents Chemother 2002, 46, 3187-3822.
40. S. P. Cohen, L. M. McMurry, S. B. Levy, marA locus causes decreased expression of OmpF porin in multiple-antibiotic-resistant (Mar) mutants of Escherichia coli. J. Bacteriol. 1988, 170, 5416-5422.
41. S. P. Cohen, S. B. Levy, J. Foulds, J. L. Rosner, Salicylate induction of antibiotic resistance in E coli: activation of the mar operon and a mar-independent pathway. J. Bacteriol. 1993, 175, 7856-7862.
42. L. A. Pratt, W. Hising, K. E. Gibson, T. J. Silhavy, From acids to osmZ: multiple factor influence synthesis of the OmpF and OmpC porins in Escherichia coli. Mol Microbiol 1996, 20, 911-917.
43. A. M. George, R. M. Hall, H. W. Stokes, Multidrug resistance in Klebsiella pneumoniae: a novel gene, ramA, confers a multidrug resistance phenotype in Escherichia coli. Microbiology 1995, 141, 1909-1920.
44. M. N. Alekshun, S. B. Levy, The mar regulon: multiple resistance to antibiotics and other toxic chemicals. Trends Microbiol 1999, 7, 410-3.
45. P. F. Miller, M. C. Sulavik, Overlaps and parallels in the regulation of intrinsic multiple-antibiotic resistance in Escherichia coli. Mol Microbiol 1996, 21, 441-448.
46. E.-B. Goh, G. Yim, W. Tsui, J. A. McClure, M. G. Surette, J. Davies, Transcriptional modulation of bacterial gene expression by subinhibitory concentrations of antibiotics. Proc Natl Acad Sci USA 2002, 99, 17025-17030.
47. C. Bornet, R. Chollet, M. Malléa, J. Chevalier, A. Davin-Régli, J.-M. Pagès, C. Bollet, Imipenem and expression of multidrug efflux pump in Enterobacter aerogenes. Biochem Biophys Res Commun 2003, 301, 985-990.
48. J. Stoorvogel, J. A. W. M. van Bussel, J. A. M. van de Klundert, Biological characterization of Enterobacter cloacae outer membrane protein (OmpX). J Bacteriol 1990, 173, 161-167.
49. S. Gayet, R. Chollet, G. Molle, J.-M. Pagès, J. Chevalier, Modification of outer membrane protein profile and evidence suggesting an active drug pump in Enterobacter aerogenes clinical strains. Antimicrob Agents Chemother 2003, 47, 1555-1559.
50. E. Dé, A. Baslé, M. Jaquinod, N. Saint, M. Malléa, G. Molle, J.-M. Pagès, A new mechanism of antibiotic resistance in Enterobacteriaceae induced by a structural modification of the major porin. Mol Microbiol 2001, 41, 189-198.
51. A. Domenech-Sanchez, S. Hernandez-Alles, L. Martinez-Martinez, V. J. Benedi, S. Alberti, Identification and characterization of a new porin gene of Klebsiella pneumoniae: its role in β-lactam antibiotic resistance. J Bacteriol 1999, 181, 2726-2732.
52. M. B. Martinez, M. Flickinger, L. A. Higgins, T. Krick, G. L. Nelsestuen, Reduced outer membrane permeability of Escherichia coli O157:H7: suggested role of modified outer membrane porins and theoretical function in resistance to antimicrobial agents. Biochemistry 2001, 40, 11965-11974.
53. M. Olesky, M. Hobbs, R. A. Nicholas, Identification and analysis of amino acid mutations in porin IB that mediate intermediate-level resistance to penicillin and tetracycline in Neisseria gonorrhoeae. Antimicrob Agents Che-mother 2002, 46, 2811-2820.
54. W. L. Veal, R. A. Nicholas, W. M. Shafer, Overexpression of the MtrC-MtrD-MtrE efflux pump due to an mtrR mutation is required for chromosomally mediated penicillin resistance in Neisseria gonorrhoeae. J Bacteriol 2002, 184, 5619-5624.
55. M. A. Arbing, J. W. Hanrahan, J. W. Coulton, Altered channel properties of porins from Haemophilus influenzae: isolates from cystic fibrosis patients. J Membr Biol 2002, 189, 131-141.
56. J. Chevalier, J.-M. Pagès, M. Malléa, In vivo modification of porin activity conferring antibiotic resistance to Enterobacter aerogenes. Biochem Biophys Res Commun 1999, 266, 248-251.
57. D. Jeanteur, T. Schirmer, D. Fourel, V. Simonet, G. Rummel, C. Widmer, J. P. Rosenbusch, F. Pattus, J.-M. Pagès, Structural and functional alterations of a colicin-resistant mutant of OmpF porin from Escherichia coli. Proc Natl Acad Sci USA 1994, 91, 10675-10679.
58. V. Simonet, M. Malléa, J.-M. Pagès, Substitutions in the eyelet region disrupt cefepime diffusion through the Escherichia coli OmpF channel. Antimicrob Agents Chemother 2000, 44, 311-315.
59. L. Martinez-Martinez, A. Pascual, M. del Carmen Conejo, I. Garcia, P. Joyanes, A. Domenech-Sanchez, V. Javier Benedi, Energy-dependant accumulation of norfloxacin and porin expression in clinical isolates of Klebsiella pneumoniae and relationship to extended-spectrum β-lactamase production. Antimicrob Agents Chemother 2002, 46, 3926-3932.
60. S. Hernandez-Alles, S. Alberti, D. Alvarez, A. Dominguez-Sanchez, L. Martinez-Martinez, J. Gil, J. M. Tomas, V. J. Benedi, Porin expression in clinical isolates of Klebsiella pneumoniae. Microbiology 1999, 145, 673-679.
61. M. J. Gill, S. Simjee, K. Al-Hattawi, B. D. Robertson, C. S. F. Easmon, C. A. Ison, Gonococcal resistance to β-lactams and tetracycline involves mutation in loop 3 of the porin encoded at the pen B locus. Antimicrob Agents Chemother 1998, 42, 2799-2803.
62. N. Carbonetti, V. Simnad, C. Elkins, P. F. Sparling, Construction of isogenic gonococci with variable porin structure: effects on susceptibility to human serum and antibiotics. Mol Biol 1990, 4, 1009-1018.
63. A. Karshikoff, V. Spassov, S. A Cowan, R. Ladenstein, T. Schirmer, Electrostatic properties of two porin channels from Escherichia coli. J Mol Biol 1994, 240, 372-377.
64. P. Van Gelder, N. Saint, R. van Boxtel, J. P. Rosenbusch, J. Tommassen, Pore functioning of outer membrane protein PhoE of Escherichia coli: mutagenesis of the constriction loop L3. Protein Eng 1997, 10, 699-706.
65. E. F. Eppens, N. Saint, P. Van Gelder, R. van Boxtel, J. Tommassen, Role of the constriction loop in the gating of outer membrane porin PhoE of Escherichia coli. FEBS Lett 1997, 415, 317-320.
66. S. A. Benson, J. L. L. Occi, B. A. Sampson, Mutations that alter the pore function of the OmpF porin of Escherichia coli K12. J Mol Biol 1988, 203, 961-970.
67. R. Misra, S. A. Benson, Genetic identification of the pore domain of the OmpC porin of Escherichia coli K-12. J Bacteriol 1988, 170, 3611-3617.
68. T. Mizuno, M. Y. Chou, M. Inouye, A comparative study on the genes for three porins of the Escherichia coli outer membrane. J Biol Chem 1983, 11, 6932-6940.
69. J. Bredin, N. Saint, M. Malléa, E. Dé, G. Molle, J.-M. Pagès, V. Simonet. Alteration of pore properties of Escherichia coli OmpF induced by mutation of key residues in anti-loop3 region. Biochem J 2002, 363, 521-528.
70. Y. Nitzan, E. Bokobza Deutsch, I. Pechatnikov, Diffusion of ß-lactam antibiotics through oligomeric or monomeric porin channels of some Gramnegative bacteria. Curr Microbiol 2002, 45, 446-455.
71. E. K. Nestorovich, C. Danelon, M. Winterhalter, S. M. Bezrukov, Designed to penetrate: time-resolved interaction of single antibiotic molecules with bacterial pores. Proc Natl Acad Sci USA 2002, 99, 9789-9794.
72. P. Plesiat, H. Nikaido, Outer membranes of Gram-negative bacteria are permeable to steroid probes. Mol Microbiol 1992, 6, 1323-1333.
73. R. E. Hencock, The bacterial outer membrane as a drug barrier. Trends Microbiol 1997, 5, 37-42.
74. H. Samartzidou, M. Mehrazin, Z. Xu, M. J. Benedik, A. H. Delcour, Cadaverine inhibition of porin plays a role in cell survival at acidic pH. J Bacteriol. 2003, 185, 13-19.
75. D. Hocquet, X. Bertrand, T. Köhler, D. Talon, P. Plésiat, Genetic and phenotypic variations of a resistant Pseudomonas aeruginosa epidemic clone. Antimicrob Agents Chemother 2003, 47, 1887-1894.